TPO antibodies blood test
Thyroid peroxidase antibodies (TPOAb, anti-TPO). Also called: TPOAb, Anti-TPO, Thyroid peroxidase antibody, Antithyroid peroxidase antibodies, Thyroid microsomal antibodies
TPO antibodies attack thyroid peroxidase, the enzyme that makes thyroid hormone. A positive result means thyroid autoimmunity, the usual cause of Hashimoto's. Labcorp reads above 34 IU/mL as high and Quest 9 IU/mL or more.
At a glance
| What it measures | Antibodies against thyroid peroxidase, the enzyme the thyroid uses to make hormone. They mark autoimmune thyroid disease. |
|---|---|
| Sample | Serum (preferred) or plasma. Stop high-dose biotin at least 72 hours before. |
| Adult cut-offs | Labcorp 0-34 IU/mL (over 19 years); Quest below 9 IU/mL. Cut-offs depend on the assay, so compare results from the same lab. |
| Peptides | No peptide has been shown to change TPO antibodies: they did not change on Exenatide, and case reports link Leuprolide and Triptorelin to new thyroiditis. |
| Lab code | LOINC 8099-4 (Labcorp 006676, Quest 5081; both antibodies: Labcorp 006684, Quest 7260) |
What are TPO antibodies?
Thyroid peroxidase (TPO) is the enzyme the thyroid uses to make thyroid hormone; it is the "microsomal antigen" that older antibody tests detected. TPO antibodies are present in 70% to 90% of people with chronic autoimmune thyroiditis (Hashimoto's). They are the most sensitive blood test for thyroid autoimmunity, and they help explain why TSH is raised and how likely an underactive thyroid is to progress.
How it is made and regulated
Where it is made
The immune system makes the antibodies against the body's own thyroid peroxidase. They are a marker of the autoimmune process that, in Hashimoto's, slowly damages the thyroid.
What controls it
Positive antibodies often appear before thyroid function changes. In a 20-year community study, positive thyroid antibodies alone raised the odds of later hypothyroidism 8-fold in women, and raised TSH with positive antibodies 38-fold.
Sources: [5]
How it travels in the blood
The tests are immunoassays reported in IU/mL, not titers. Labcorp uses an electrochemiluminescence assay on the Roche cobas and Quest an immunoassay; their cut-offs differ, so results cannot be compared between labs.
How long it lasts
Antibody levels may wane over time, but repeated measurements do not improve the monitoring of an individual patient, so one positive result is usually enough.
Sources: [3]
What it does
In subclinical hypothyroidism, progression to overt hypothyroidism is faster with positive TPO antibodies: 4.3% a year compared with 2.6% a year without them.
Sources: [3]
Reference ranges
There is no "normal" level beyond the lab's cut-off: a result above it is positive. Labcorp prints age bands for children; neither lab prints a pregnancy range.
Labcorp (test 006676)
| Group | Range (IU/mL) |
|---|---|
| Over 19 years | 0-34 |
Children and teens
| Group | Range (IU/mL) |
|---|---|
| 0 to 6 days | 0-117 |
| 7 days to 3 months | 0-47 |
| 4 to 11 months | 0-32 |
| 1 to 5 years | 0-13 |
| 6 to 10 years | 0-18 |
| 11 to 19 years | 0-26 |
As printed on Labcorp's test page for 006676. No pregnancy range is printed.
Quest Diagnostics (test 5081)
| Group | Range (IU/mL) |
|---|---|
| Reference range | below 9 |
From Quest's test directory; the same cut-off is used on Quest's combined antibody test (7260).
Cut-offs are specific to each assay (positive above 34 IU/mL at Labcorp, 9 or more at Quest), so a result from one lab cannot be read against the other's range.
Is there an "optimal" range?
There is no "optimal" TPO antibody level. The debate is about when to test, how to read a positive result, and whether to repeat it.
The lab cut-off
Labcorp 0-34; Quest below 9 IU/mL
Labcorp 006676 and Quest 5081
Each lab sets its own cut-off for its assay; above it the result is reported as positive.
Test once, do not monitor
One positive result is enough
European Thyroid Association (2013)
TPO antibodies give the cause of a raised TSH and the risk of progression, but repeated measurements do not improve monitoring of an individual patient.
Sources: [3]
Screen before fertility treatment
TSH and TPO antibodies before IVF
European Thyroid Association (2021)
Raised TPO antibodies can identify women at risk of hypothyroidism after ovarian stimulation or during pregnancy, and of postpartum thyroiditis.
Sources: [8]
Do not treat the antibodies alone
No levothyroxine for normal thyroid function
TABLET trial (2019)
In 952 euthyroid women with TPO antibodies and miscarriage or subfertility, levothyroxine did not raise the live-birth rate (37.4% vs 37.9% on placebo).
Sources: [9]
What raises it
| Factor | How | How much |
|---|---|---|
| Hashimoto's (chronic autoimmune thyroiditis)Condition | TPO antibodies are found in 70% to 90% of people with chronic thyroiditis. | No published magnitude [2] |
| Graves disease and other thyroid autoimmunityCondition | Quest lists Graves disease, endemic goiter and polyendocrine autoimmune disorders among the conditions the test helps diagnose. | No published magnitude [6] |
| Other autoimmune diseasesCondition | Labcorp notes positive results in Sjögren's syndrome, lupus, rheumatoid arthritis and pernicious anemia. | No published magnitude [2] |
| GnRH agonists (case reports)Peptide | Case reports describe thyroiditis with new or rising antibodies after Leuprolide or Triptorelin. | No published magnitude [10] [11] |
| Asfotase alfa (false result)Medication | Quest notes that Strensiq (asfotase alfa) may falsely raise the result. | No published magnitude [6] |
What lowers it
| Factor | How | How much |
|---|---|---|
| TimePhysiology | Antibody levels may wane over the years, although repeat testing does not help monitoring. | No published magnitude [3] |
| Recovery from painless thyroiditisCondition | In a case of thyroiditis after Leuprolide, the antibodies gradually decreased as the thyroid recovered. | No published magnitude [12] |
Peptides that affect TPO antibodies
How each peptide in our library has been shown to change TPO antibodies. The evidence is thin: one study measured them before and after a peptide (Exenatide, no change), and the GnRH-agonist rows are case reports. A single case of antibodies turning positive after Octreotide in a woman with a TSH-secreting pituitary tumor, and a single antibody-negative case of thyroiditis on Tirzepatide, are not listed as rows. In a 2026 health-record study, people starting GLP-1 drugs were diagnosed with autoimmune thyroiditis slightly more often than those starting DPP-4 inhibitors (0.49% vs 0.39%), but antibodies were not measured. No study has measured TPO antibodies after dosing Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, Retatrutide, Thymosin Alpha-1, Thymulin, TB-500, LL-37, KPV, Selank, Semax, BPC-157, the growth hormone peptides or Leptin in people; PubMed searches for each find no human titer data (Thymalin has one study of 82 patients with autoimmune thyroiditis that reports only T-cell results). The rest of our library has no human TPO antibody data either.
| Peptide | Effect on TPO antibodies | Size of effect | Evidence |
|---|---|---|---|
| Exenatide | No clear effect | 39 obese adults with type 2 diabetes, exenatide 5 then 10 μg twice daily for 6 months (before-after, no control group): anti-TPO median 1.3 to 1.5 IU/mL (p = 0.106), while TSH and thyroid volume fellTPO antibodies did not change over 6 months on exenatide; the only GLP-1 study that measured them. [13] | Human trials |
| Leuprolide | Unclear | Case reports only: painless thyroiditis with a rise in antithyroid microsomal antibodies at 4 months after starting leuprolide (1 patient); silent thyroiditis after the fifth monthly injection with anti-TPO and anti-Tg positive, then gradually decreasing (1 patient); positive anti-TPO (58 U/mL; >100 U/mL) when thyroid dysfunction was found after leuprorelin 3.75 mg monthly (3 Korean cases). In 73 girls on leuprorelin or triptorelin for 40.4 months, thyroid antibodies were measured every 6 months and no thyroid dysfunction was found; the abstract gives no antibody resultsCase reports link GnRH-agonist treatment to the onset of autoimmune thyroiditis; the one cohort found no thyroid dysfunction. [10] [12] [14] [15] | Human trials |
| Triptorelin | Unclear | Case reports only: transient hyperthyroidism 2 weeks after a triptorelin injection in three women, two of them with positive antithyroid microsome and/or thyroglobulin antibodies (no pre-treatment titers); after 8 years of monthly triptorelin for precocious puberty, one of two girls had elevated thyroid antibodies with autoimmune thyroiditis. The 73-girl leuprorelin/triptorelin cohort found no thyroid dysfunctionIsolated cases of autoimmune thyroiditis appearing on triptorelin; no controlled antibody data. [11] [16] [15] | Human trials |
What high or low results can mean
A high result
Above 34 IU/mL at Labcorp, or 9 or more at Quest, is positive: the immune system is reacting against the thyroid. With a raised TSH it points to Hashimoto's as the cause; with a normal TSH it raises the chance of hypothyroidism later.
- Hashimoto's (chronic autoimmune thyroiditis)
- Graves disease
- Postpartum or painless thyroiditis
- Other autoimmune diseases
A low result
Below the cut-off is negative: no thyroid autoimmunity was detected by this test. It does not rule it out, because a minority of people with chronic thyroiditis test negative, and some have only thyroglobulin antibodies.
- No thyroid autoimmunity
- Antibody-negative thyroiditis
How the test works
| Sample | Serum (preferred) or plasma, 1 mL at Labcorp; 1 mL of serum at Quest. |
|---|---|
| Fasting | Labcorp lists no fasting requirement. |
| Timing | Usually ordered when TSH is raised, to find the cause, or before and during pregnancy. Stop high-dose biotin at least 72 hours before; asfotase alfa (Strensiq) can falsely raise the result at Quest. |
| Lab differences | Immunoassays reported in IU/mL: ECLIA on the Roche cobas at Labcorp, an immunoassay at Quest. Cut-offs are assay-specific. |
| Retesting | One positive result is usually enough: repeated antibody measurements do not improve monitoring. Follow TSH instead. |
| Labcorp order code | 006676: Thyroid Peroxidase (TPO) Antibodies |
| Labcorp order code | 006684: Thyroid Antibodies (TPO and thyroglobulin) |
| Quest Diagnostics order code | 5081: Thyroid Peroxidase Antibodies (TPO) |
| Quest Diagnostics order code | 7260: Thyroid Peroxidase and Thyroglobulin Antibodies |
| LOINC codes |
|
History
Thyroid antibodies were among the first autoantibodies ever found, and they established Hashimoto's as an autoimmune disease.
- 1956Roitt and colleagues describe auto-antibodies in Hashimoto's disease, one of the first autoimmune diseases recognized. [4]
- 1985Czarnocka and colleagues show that the "microsomal antigen" targeted in autoimmune thyroid disease is thyroid peroxidase. [1]
- 1995The 20-year follow-up of the Whickham survey shows that thyroid antibodies predict later hypothyroidism. [5]
- 2019The TABLET trial finds that levothyroxine does not improve live births in euthyroid women with TPO antibodies. [9]
FAQ
What is a normal TPO antibody level?
Below the lab's cut-off: 0-34 IU/mL at Labcorp for adults and below 9 IU/mL at Quest. Labcorp's ranges for children are lower or higher by age.
Do I have Hashimoto's if my TPO antibodies are positive?
Not necessarily. A positive result shows thyroid autoimmunity, the usual cause of Hashimoto's, but whether your thyroid is underactive depends on TSH and free T4. With a raised TSH, positive TPO antibodies point to Hashimoto's as the cause.
Can TPO antibodies appear before thyroid disease?
Yes. In a 20-year community study, positive thyroid antibodies alone raised the odds of later hypothyroidism 8-fold in women and 25-fold in men.
Sources: [5]
How quickly does an underactive thyroid progress with positive TPO antibodies?
In subclinical hypothyroidism, about 4.3% a year progress to overt hypothyroidism with positive TPO antibodies, compared with 2.6% a year without them.
Sources: [3]
Should TPO antibodies be rechecked during treatment?
Usually not. Levels may wane over time, but repeated measurements do not improve monitoring; treatment is guided by TSH.
Sources: [3]
Why do Labcorp and Quest use different cut-offs?
They use different assays: Labcorp reads above 34 IU/mL as positive and Quest 9 IU/mL or more. Compare results from the same lab.
What do thyroid antibodies mean for pregnancy and fertility?
European guidance suggests testing TSH and TPO antibodies in women of subfertile couples planning IVF, because raised TPO antibodies can identify women at risk of hypothyroidism during pregnancy and of postpartum thyroiditis. Levothyroxine before conception did not improve outcomes in euthyroid antibody-positive women: in the TABLET trial of 952 women, live births were 37.4% on levothyroxine and 37.9% on placebo. The American Thyroid Association updated its pregnancy guideline in 2026.
What is postpartum thyroiditis?
An autoimmune inflammation of the thyroid in the first year after giving birth, affecting about 5% of women. Women who have had it are at risk of further episodes and of permanent hypothyroidism, and raised TPO antibodies are a predictive marker for it.
Can TPO antibodies be positive without thyroid disease?
Yes. They can be positive with normal thyroid function, and also in other autoimmune diseases such as Sjögren's syndrome, lupus, rheumatoid arthritis and pernicious anemia.
Should I test TPO or thyroglobulin antibodies?
TPO antibodies are the more sensitive test for thyroid autoimmunity. European guidance adds thyroglobulin antibodies when TSH is above 2.5 and TPO antibodies are not raised; both labs offer the two together (Labcorp 006684, Quest 7260).
Do I need to stop biotin before the test?
Yes, if you take high-dose biotin: Labcorp asks you to stop at least 72 hours before.
Sources: [2]
Do any peptides affect TPO antibodies?
None has been shown to. They did not change over 6 months on Exenatide (median 1.3 to 1.5 IU/mL), and case reports link Leuprolide and Triptorelin to new thyroiditis in people with antibodies. No study has measured them on Semaglutide, Tirzepatide or Thymosin Alpha-1; a 2026 health-record study found slightly more autoimmune thyroiditis diagnoses on GLP-1 drugs than on DPP-4 inhibitors (0.49% vs 0.39%), without measuring antibodies.
References
- Czarnocka B, Ruf J, Ferrand M, et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett. 1985;190(1):147-52. PMID 2995127
- Labcorp. Test 006676: Thyroid Peroxidase (TPO) Antibodies. Use, limitations, methodology, specimen requirements, reference range by age and LOINC map. labcorp.com/tests/006676/thyroid-peroxidase-tpo-antibodies
- Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-28. PMID 24783053
- ROITT IM, DONIACH D, CAMPBELL PN, et al. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956;271(6947):820-1. PMID 13368530
- Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68. PMID 7641412
- Quest Diagnostics. Test code 5081: Thyroid Peroxidase Antibodies (TPO). Test directory: methodology, clinical significance, reference range and LOINC. testdirectory.questdiagnostics.com/test/test-detail/5081/thyroid-peroxidase-antibodies-tpo?cc=PHP
- Quest Diagnostics. Test code 7260: Thyroid Peroxidase and Thyroglobulin Antibodies. Test directory: components, reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/7260/thyroid-peroxidase-and-thyroglobulin-antibodies?cc=PHP
- Poppe K, Bisschop P, Fugazzola L, et al. 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. Eur Thyroid J. 2021;9(6):281-295. PMID 33718252
- Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. N Engl J Med. 2019;380(14):1316-1325. PMID 30907987
- Amino N, Hidaka Y, Takano T, et al. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues. Thyroid. 2003;13(8):815-8. PMID 14558924
- Miao J, Yan Q, Wang L, et al. Three cases of transient hyperthyroidism after triptorelin treatment - case report and literature review. Gynecol Endocrinol. 2018;34(9):734-735. PMID 29484896
- Kasayama S, Miyake S, Samejima Y. Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate. Endocr J. 2000;47(6):783-5. PMID 11228054
- Köseoğlu D, Özdemir Başer Ö, Berker D, et al. EXENATIDE TREATMENT REDUCES THYROID GLAND VOLUME, BUT HAS NO EFFECT ON THE SIZE OF THYROID NODULES. Acta Endocrinol (Buchar). 2020;16(3):275-279. PMID 33363646
- Han EJ, Song HD, Yang JH, et al. Thyroid dysfunction associated with administration of the long-acting gonadotropin-releasing hormone agonist. Endocrinol Metab (Seoul). 2013;28(3):221-5. PMID 24396682
- Massart F, Harrell JC, Federico G, et al. Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty. J Adolesc Health. 2007;40(3):252-7. PMID 17321426
- Krstevska-Konstantinova M, Jancevska A, Gucev Z. Autoimmune thyroiditis and diabetes mellitus type 1 after long-term gonadotropin-releasing hormone agonist treatment for central precocious puberty: evolution or coincidence? J Pediatr Endocrinol Metab. 2010;23(4):403-6. PMID 20583547
- Korevaar TIM, Leung AM, Alexander EK, et al. American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. Thyroid. 2026;36(5):481-544. PMID 42219800
- Nguyen CT, Mestman JH. Postpartum Thyroiditis. Clin Obstet Gynecol. 2019;62(2):359-364. PMID 30844908
- Labcorp. Test 006684: Thyroid Antibodies (thyroid peroxidase and thyroglobulin antibodies). Components and LOINC map. labcorp.com/tests/006684/thyroid-antibodies
- Hsiao CC, Tsai MH, Jhu JY, et al. Association of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes. Int J Med Sci. 2026;23(11):3494-3505. PMID 42910111
Educational information, not medical advice. Lab ranges and test codes were checked on November 3, 2026. Always use the range printed on your own report, and talk to a clinician about your results.